# KESIMPTA
> **BLA125326** · Biologics License Application · Sponsor: NOVARTIS · Approved 2009-10-26
## Drug
- **FDA Application Number:** BLA125326
- **Application type:** Biologics License Application
- **Brand name:** KESIMPTA
- **Generic name:** OFATUMUMAB
- **Active ingredients:** OFATUMUMAB
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2009-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125326)
---
*MORVS · CC0 1.0*